Missing data in clinical trials remains an ongoing concern. With the expansion of data privacy efforts and the consequent inability to contact trial participants for follow-up, the magnitude and ...

Data is almost always incomplete. Patients drop out of clinical trials and survey respondents skip questions; schools fail to report scores, and governments ignore elements of their economies. When ...

While electronic health records present a rich and promising data source for observational research, they are highly susceptible to missing data. For settings like these, Seaman et al. (Biometrics 68 ...

Mineralys Therapeutics, Inc. (($MLYS)) has held its Q3 earnings call. Read on for the main highlights of the call. Mineralys Therapeutics, Inc.